Addition of boceprevir and telaprevir economically viable Clinical study 14 January 2013 Pages: 3 - 3
Discontinuation of tamoxifen by younger women raises concerns Clinical study 14 January 2013 Pages: 4 - 4
Incidence, cost of neonatal abstinence syndrome increasing Clinical study 14 January 2013 Pages: 4 - 4
Adherence with COPD and CHB treatment guidelines appropriate? Clinical study 14 January 2013 Pages: 5 - 5
Better adherence a double-edged sword for children with asthma Clinical study 14 January 2013 Pages: 6 - 6
Early intervention cost effective for acute migraine in France Clinical study 14 January 2013 Pages: 6 - 6
PSA-based prostate cancer screening rates remain unchanged Clinical study 14 January 2013 Pages: 8 - 8
Cost effectiveness of CRT-D in the US - candidate selection important Clinical study 14 January 2013 Pages: 9 - 9
Initiating inhaled iloprost for PAH cost effective in Spain Clinical study 14 January 2013 Pages: 9 - 9
Which biological treatment for Crohn’s disease in the US? Clinical study 14 January 2013 Pages: 9 - 9
Affordable Care Act costly for the pharmaceutical industry Media release 14 January 2013 Pages: 10 - 10
Ontario’s pharmacists unhappy with generic drug price cuts Media release 14 January 2013 Pages: 10 - 10